Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone

NCT00396357 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

914

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Vildagliptin
DRUG: metformin

Sponsor

Novartis Pharmaceuticals